Ultragenyx Pharmaceutical, Inc. (RARE)
21.34
-0.37
(-1.70%)
USD |
NASDAQ |
Mar 13, 16:00
21.11
-0.23
(-1.08%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Shareholders Equity (Quarterly) : -80.00M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Johnson & Johnson | 81.54B |
| CorMedix, Inc. | 405.31M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Insmed, Inc. | 738.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.532B |
| Total Liabilities (Quarterly) | 1.605B |
| Debt to Equity Ratio | -15.65 |
| Current Ratio | 2.477 |
| Net Debt Paydown Yield | -3.06% |